DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Lymecycline is an investigational drug.
There have been 3 clinical trials for Lymecycline. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.
The most common disease conditions in clinical trials are Uterine Cervicitis, Urethritis, and Pleuropneumonia. The leading clinical trial sponsors are Ostergotland County Council, Sweden, Statens Serum Institut, and Galderma.
Recent Clinical Trials for Lymecycline
|Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced||Statens Serum Institut||Phase 4|
|Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced||Ostergotland County Council, Sweden||Phase 4|
|Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris||Galderma||Phase 3|